Fanconi anemia - learning from children

Pediatric Reports

Volumn 3, Issue 2S, 2011, Pages 18-20

  Svahn, Johanna ^a   Dufour, Carlo ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Anemia; Fanconi

Indexed keywords

EID: 84860897722     PISSN: None     EISSN: 20367503     Source Type: Journal    
DOI: 10.4081/pr.2011.s2.e8     Document Type: Article

References (23)

1. Alter BP. Inherited Bone Marrow Failure Syndromes: Fanconi Anemia. In: D.G Nathan et al., editors. Nathan and Oski's Hematology of Infancy and Childhood. 6th edition, Philadelphia: Saunders; 2003. p. 281-299.
2. Tipping AJ, Pearson T, Morgan NV, et al. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A 2001;98:5734-9.
3. Callen E, Casado JA, Tischkowitz MD, et al. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood 2005;105:1946-9.
4. Mehta PA, Harris RE, Davies SM, et al. Numerical chromosomal changes and risk of development of myelodysplastic syndromeacute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet 2010;203:180-6.
5. Pasquini R, Carreras J, Pasquini MC, et al. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant 2008; 14:1141-7.
6. Wagner JE, Eapen M, MacMillan ML, et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007;109:2256-62.
7. MacMillan ML, Blazar BR, DeFor TE, et al. Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study. Biol Blood Marrow Transpl 2009;15:3-4.
8. Motwani J, Lawson SE, Darbyshire PJ. Successful HSCT using nonradiotherapybased conditioning regimens and alternative donors in patients with Fanconi anaemia-experience in a single UK centre. Bone Marrow Transplant 2005; 36:405-10.
9. Bonfim CM, de Medeiros CR, Bitencourt MA, et al. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biol Blood Marrow Transplant 2007;13:1455-60.
10. Gluckman E, Rocha V, Ionescu I, et al. Eurocord- Netcord and EBMT. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007;13:1073-82.
11. Rosenberg PS, Socié G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005;105:67-73.
12. Guardiola P, Pasquini R, Dokal I, et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLAmatched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000;95: 422-9.
13. de Medeiros CR, Bitencourt MA, Zanis- Neto J, et al. Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution. Braz J Med Biol Res 2006;39:1297-304.
14. Vadnerkar A, Nguyen MH, Mitsani D, et al. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant 2010;29:1240-4.
15. Dufour C, Corcione A, Svahn J, et al. TNFalpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. Blood 2003;102:2053-9.
16. Mehta PA, Ileri T, Harris RE, et al. Chemotherapy for myeloid malignancy in children with Fanconi anemia. Pediatr Blood Cancer 2007;48:668-72.
17. MacMillan ML, Wagner JE. Haemato - poeitic cell transplantation for Fanconi anaemia-when and how? Br J Haematol 2010;149:14-21.
18. Dufour C, Rondelli R, Locatelli F, et al. Stem cell transplantation from HLAmatched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO. Br J Haematol 2001;112: 796-805.
19. Farzin A, Davies SM, Smith FO, et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. Br J Haematol 2007; 136:633-40.
20. Tan PL, Wagner JE, Auerbach AD, et al. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 2006;46:630-6.
21. Ayas M, Al-Jefri A, Al-Seraihi A, et al. Matched-related allogeneic stem cell transplantation in Saudi patients with Fanconi anemia: 10 year's experience. Bone Marrow Transplant 2008;42:S45-8.
22. Chaudhury S, Auerbach AD, Kernan NA, Small TN, et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol 2008;140:644-55.
23. Yabe H, Inoue H, Matsumoto M, et al. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia. Br J Haematol 2006;134: 208-12.